What triggers the immune response against myelin in MS?
29 March 2023
Subtle changes in the myelin sheath can spark inflammation in the brain, a new Australian study has found.
Subtle changes in the myelin sheath can spark inflammation in the brain, a new Australian study has found.
CEO Rohan Greenland talks about the iconic annual fundraising event for MS research – The May 50K! He discusses his personal connections to MS that motivate him to take on the challenge and how each dollar raised supports our world-class MS researchers.
Back for its fifth year, The May 50K combines fitness and fundraising to help leave MS where it
Vic and Kathy met in 1986, and their love endured long past Kathy’s death in 1998, at only 41, from complications arising from multiple sclerosis (MS).
REBIF (interferon beta-1a) and AVONEX (interferon beta-1a) are currently used for the treatment of Australians living with relapsing forms of MS. Recently, there were some changes announced to their listing on the PBS.
From 1 April 2023, AVONEX will no longer be available on the Pharmaceutical Benefits Scheme (PBS) for Australians living with MS.
MS Australia is delighted to announce over $3 million of funding towards MS research in 2023. The twenty-two new projects address MS Australia’s priorities for MS research, including causes and prevention, better treatments and cures via repair and regeneration of cells.
CEO Rohan Greenland discusses the dramatic escalation in the number of people in Australia living with MS and urges the government to take action so that we can work together to turn the tables on MS. Â
A recent study from researchers in Perth has explored the impact of COVID-19 on people living with MS and MS carers, investigating both the highs and lows of the pandemic. A deeper understanding of these experiences can help inform future crises as they unfold, to ensure the best care and health management possible for people living with MS, their carers and loved ones.